Grace Therapeutics, Inc. (GRCE)
NASDAQ: GRCE · Real-Time Price · USD
2.120
+0.020 (0.95%)
Sep 8, 2026, 4:00 PM EDT - Market closed
Grace Therapeutics Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
5
Market Cap
44.60M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | - | - | - |
| Mar 31, 2025 | - | - | - |
| Mar 31, 2024 | - | - | - |
| Mar 31, 2023 | - | - | - |
| Mar 31, 2022 | - | - | - |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Karyopharm Therapeutics | 146.62M |
| Actinium Pharmaceuticals | 35.09M |
| Celularity | 26.55M |
| Werewolf Therapeutics | 21.00M |
| Veru Inc. | 16.89M |
| Immutep | 13.79M |
| Metagenomi Therapeutics | 13.56M |
| Mereo BioPharma Group | 500.00K |
GRCE News
- 5 days ago - Grace Therapeutics to Participate in the H.C. Wainright 28th Annual Global Investment Conference - GlobeNewsWire
- 15 days ago - Grace Therapeutics files to sell 4.76M shares of common stock for holders - TheFly
- 15 days ago - Grace Therapeutics Registration statement: Registration filing - Filings
- 26 days ago - Grace Therapeutics Announces First Quarter 2027 Financial Results, Provides Business Update - GlobeNewsWire
- 27 days ago - Grace Therapeutics Quarterly report: Q1 2027 - Filings
- 27 days ago - Grace Therapeutics Earnings release: Q1 2027 - Filings
- 5 weeks ago - Grace Therapeutics to issue 4.762M shares at $2.10 in private placement - TheFly
- 5 weeks ago - Grace Therapeutics initiates dual-source manufacturing strategy for GTx-104 - TheFly